The only newsletter at the intersection of biotech, politics, and policy
May 9, 2022
We meet the 2022 World Food Prize Laureate, and take a deep dive into the FDA’s new draft guidance on non-opioid analgesics and BIO’s response. (642 words, 3 minutes, 12 seconds)
World Food Prize recognizes links between climate and food systems
Dr. Cynthia Rosenzweig was awarded the 2022 World Food Prize for her work exploring how climate change impacts our food systems. BIO’s VP of Agriculture and Environment Sarah Gallo attended the ceremony and shared with us why this research is more important than ever.
What:The World Food Prize is awarded annually to an individual whose work advances “human development with a demonstrable increase in the quantity, quality, availability of, or access to food through creative interventions at any point within the full scope of the food system.”
How: “Through designing and leading rigorous, collaborative observational and modeling research, she provided the evidence used by thousands of decision-makers in more than 90 countries to both mitigate and adapt to climate change in local, national and global food systems,” says the World Food Prize Foundation.
The context: The opioid epidemic killed more than 70,000 in the U.S. in 2019 alone—with the crisis intensifying during the pandemic. New non-opioid analgesics are needed to help alleviate patient suffering, particularly those with chronic pain, while mitigating the risks of using opioids.
BIO has several concerns—including the fact that the five-year delay has put development of non-opioid alternatives on hold, and that the guidance does not address chronic pain, said BIO’s comments to FDA.
Furthermore: “[E]stablishing an unnecessarily high threshold for supporting a general acute pain indication could discourage the development of novel analgesic drugs for such uses,” continued BIO.
NBC News: COVID’s toll in the U.S. reaches a once unfathomable number: 1 million deaths “The number—equivalent to the population of San Jose, California, the 10th largest city in the U.S.—was reached at stunning speed: 27 months after the country confirmed its first case of the virus.”
"I'm always excited about the BIO Convention because it gives me the opportunity to work with people from around the world with whom we collaborate to deliver products to patients—something we do best in this industry," said Joseph Panetta, President and CEO of Biocom California. "I'm looking forward to seeing you in June here in San Diego!"